Clinical Trials Logo

Clinical Trial Summary

The objective is to evaluate the safety and effectiveness of the PerQseal vascular closure device system when used to achieve haemostasis of common femoral arteriotomies created by 12 to 22 F sheaths (arteriotomy up to 26 F) in subjects undergoing percutaneous catheter-based interventional procedures.


Clinical Trial Description

The objective of this pivotal study is to evaluate the safety and effectiveness of the PerQseal vascular closure device system when used to achieve haemostasis of common femoral arteriotomies created by 12 to 22 F sheaths (arteriotomy up to 26 F) in subjects undergoing percutaneous catheter-based interventional procedures, with sufficient rigor to provide robust scientific evidence for the demonstration of clinical safety and efficacy of the PerQseal closure system to support a pre-market approval submission. ;


Study Design


Related Conditions & MeSH terms

  • Percutaneous Large Hole Vascular Closure

NCT number NCT05653336
Study type Interventional
Source Vivasure Medical Limited
Contact Chris Martin, Dr.
Phone +353 91 395 442
Email Chris.Martin@vsuremed.com
Status Recruiting
Phase N/A
Start date March 30, 2023
Completion date August 2025

See also
  Status Clinical Trial Phase
Completed NCT05163548 - PerQseal®+ Early Feasibility Study N/A
Completed NCT04818541 - PerQseal® Impella Early Feasibility Study N/A